The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
The long-serving general counsel of privately owned company Ferring Pharmaceutical has quit after the company relocated from Copenhagen to Wallisellen, Switzerland.
General counsel Patricia Barclay decided not to move with the company headquarters, which could leave Ferring without a general counsel for much of the year. She has been general counsel since 1984.
Ferring has an annual revenue of almost E600m (£413.6m) and around 2,500 employees. The replacement counsel will sit on the senior management team, reporting directly to chairman and founder Dr Frederick Paulsen. The general counsel is in charge of both the legal and patent/IP departments.
It is understood that, although applications have come in from private practice lawyers, Ferring would prefer to hire from competitors in the pharmaceutical market.
Ferring, which produces synthetic peptides for the manufacture of biopharmaceutical products, is understood to have invested E90m (£62m) in the construction of its new state-of-the-art Swiss headquarters.